Robert C. Gay serves as Executive at MERRIMACK PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Robert C. Gay has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Apr 3, 2012 involved exercising options for 175,316 shares valued at $0.
Robert C. Gay currently holds 175,316 shares of MERRIMACK PHARMACEUTICALS INC (MACK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert C. Gay has been a net neutral trader of MACK stock. They have purchased $0 and sold $0 worth of shares.
Robert C. Gay's most recent insider trade was on Apr 3, 2012, when they sold 175,316 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Apr 3, 2012 | MACK | $0 | Conversion | 142,857 | $N/A | Discretionary |
| Apr 3, 2012 | MACK | $0 | Conversion | 175,316 | $N/A | Discretionary |